CORCEPT THERAPEUTICS INC Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Corcept Therapeutics Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q2 2024.
  • Corcept Therapeutics Inc Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was $35.5M, a 28.9% increase year-over-year.
  • Corcept Therapeutics Inc Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was $126M, a 33.2% increase year-over-year.
  • Corcept Therapeutics Inc annual Net Income (Loss) Attributable to Parent for 2023 was $106M, a 4.66% increase from 2022.
  • Corcept Therapeutics Inc annual Net Income (Loss) Attributable to Parent for 2022 was $101M, a 9.86% decline from 2021.
  • Corcept Therapeutics Inc annual Net Income (Loss) Attributable to Parent for 2021 was $113M, a 6.13% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $126M $35.5M +$7.96M +28.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-29
Q1 2024 $118M $27.8M +$11.9M +74.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-07-29
Q4 2023 $106M $31.4M +$14.8M +88.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-15
Q3 2023 $91.4M $31.4M -$3.23M -9.33% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $94.6M $27.5M +$116K +0.42% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-29
Q1 2023 $94.5M $15.9M -$6.92M -30.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-07-29
Q4 2022 $101M $16.6M -$15.5M -48.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-15
Q3 2022 $117M $34.6M +$4.14M +13.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $113M $27.4M +$889K +3.35% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-01
Q1 2022 $112M $22.8M -$668K -2.85% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-01
Q4 2021 $113M $32.1M +$6.06M +23.3% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-15
Q3 2021 $106M $30.5M +$8.85M +40.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $97.6M $26.5M -$1.8M -6.37% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-03
Q1 2021 $99.4M $23.5M -$6.6M -22% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-03
Q4 2020 $106M $26M -$3.39M -11.5% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-23
Q3 2020 $109M $21.6M -$4.72M -17.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $114M $28.3M +$8.14M +40.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-03
Q1 2020 $106M $30.1M +$11.8M +64.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-03
Q4 2019 $94.2M $29.4M +$7.37M +33.5% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-23
Q3 2019 $86.8M $26.3M +$8.59M +48.4% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-23
Q2 2019 $78.2M $20.2M +$1.99M +10.9% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-23
Q1 2019 $76.2M $18.3M +$815K +4.67% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-23
Q4 2018 $75.4M $22M -$76.3M -77.6% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-24
Q3 2018 $152M $17.7M +$3.99M +29% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-24
Q2 2018 $148M $18.2M +$5.55M +43.9% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-24
Q1 2018 $142M $17.5M +$13.1M +298% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-24
Q4 2017 $129M $98.3M +$93.7M +2039% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-26
Q3 2017 $35.4M $13.8M +$11.2M +432% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-26
Q2 2017 $24.2M $12.6M +$11.7M +1194% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-26
Q1 2017 $12.5M $4.39M +$23.4M Jan 1, 2017 Mar 31, 2017 10-K 2019-02-26
Q4 2016 -$10.8M $4.6M +$3.64M +379% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-28
Q3 2016 -$14.5M $2.59M +$3.19M Jul 1, 2016 Sep 30, 2016 10-K 2018-02-28
Q2 2016 -$17.7M $977K +$2.91M Apr 1, 2016 Jun 30, 2016 10-K 2018-02-28
Q1 2016 -$20.6M -$19M -$14.2M -293% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-28
Q4 2015 -$6.41M $959K +$4.85M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-06
Q3 2015 -$11.3M -$601K +$5.41M +90% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-06
Q2 2015 -$16.7M -$1.94M +$5.62M +74.4% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-06
Q1 2015 -$22.3M -$4.83M +$9.1M +65.3% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-06
Q4 2014 -$31.4M -$3.9M +$7.23M +65% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-10
Q3 2014 -$38.6M -$6.01M +$4.9M +44.9% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-10
Q2 2014 -$43.5M -$7.55M +$4.35M +36.5% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-10
Q1 2014 -$47.9M -$13.9M -$1.85M -15.3% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-10
Q4 2013 -$46M -$11.1M $0 0% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-13
Q3 2013 -$46M -$10.9M -$2.61M -31.5% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-13
Q2 2013 -$43.4M -$11.9M -$4.3M -56.6% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-13
Q1 2013 -$39.1M -$12.1M -$1.05M -9.52% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-13
Q4 2012 -$38M -$11.1M -$1.19M -12% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-14
Q3 2012 -$36.9M -$8.29M -$1.86M -28.9% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-14
Q2 2012 -$35M -$7.6M +$1.29M +14.5% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-14
Q1 2012 -$36.3M -$11M -$3.93M -55.4% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-14
Q4 2011 -$32.4M -$9.94M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-15
Q3 2011 -$6.44M +$669K +9.42% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-15
Q2 2011 -$8.88M -$3.19M -56% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-15
Q1 2011 -$7.1M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-15
Q3 2010 -$7.1M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-08
Q2 2010 -$5.7M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.